Back
Biogen, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
50
BIIB
Biogen, Inc.
Last Price:
$174.67
Seasonality Move:
8.72%
Sell
32
NONOF
Novo Nordisk A/S
Last Price:
$48.00
Seasonality Move:
3.42%
Sell
50
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $174.80. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $48.00. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $174.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight buying pressure.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $48.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.31 | Buy |
| Relative Strength Index (14 RSI): | 54.83 | Buy |
| Chaikin Money Flow: | 7426132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (170.01 - 180.53) | Sell |
| Bollinger Bands (100): | (135.5 - 167.28) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 47.42 | Sell |
| Chaikin Money Flow: | 54114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.71 - 49.05) | Buy |
| Bollinger Bands (100): | (47.98 - 57.06) | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 173.53 | Buy |
| 20-day SMA: | 177.23 | Sell |
| 50-day SMA: | 162.95 | Buy |
| 200-day SMA: | 140.07 | Buy |
| 8-day EMA: | 173.81 | Buy |
| 20-day EMA: | 173.41 | Buy |
| 50-day EMA: | 165.39 | Buy |
| 200-day EMA: | 152.21 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.81 | Sell |
| 20-day SMA: | 47.97 | Buy |
| 50-day SMA: | 50.02 | Sell |
| 200-day SMA: | 60.74 | Sell |
| 8-day EMA: | 48.35 | Sell |
| 20-day EMA: | 48.4 | Sell |
| 50-day EMA: | 50.13 | Sell |
| 200-day EMA: | 63 | Sell |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.30 per share, and an increase next year of $0.15 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Biogen, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||